Canadian Patient Pays $90,000 a Month for New Cancer Drug, Raising Cost Concerns

Published 2026-10-27

A new cancer treatment is raising serious questions about the cost of medicine in Canada. James Howard, a patient from Vancouver, is paying $90,000 a month for a new drug to treat pancreatic cancer. The amount is about the same as a down payment on a house, and the treatment may only extend his life by a few more months.

The high price has caught the attention of some doctors, who say the cost is too high for what the drug offers. Some of these doctors have described the pricing as greed rather than a fair part of the health care system. They argue that many patients cannot afford such treatments, even when they could give them more time with their families. The report does not say how many Canadians are currently using this drug.

The case also highlights a wider debate in Canada about how new medicines are priced and who pays for them. Public health insurance covers many hospital services, but it does not always cover the full cost of expensive new drugs. Patients may need private insurance, personal savings, or government drug programs to pay for their treatment. Some people have asked the government to set stronger limits on what drug companies can charge.

For now, Mr. Howard continues his treatment and hopes it will help him. His situation shows how difficult choices about cancer care can be for patients and families. As more expensive drugs enter the market, many Canadians are likely to ask whether the health care system can keep up with the costs.

Sources: CBC

More Canada news

All Canada news · News by country